These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34154922)

  • 21. Evaluation of AAV-mediated Gene Therapy for Central Nervous System Disease in Canine Mucopolysaccharidosis VII.
    Gurda BL; De Guilhem De Lataillade A; Bell P; Zhu Y; Yu H; Wang P; Bagel J; Vite CH; Sikora T; Hinderer C; Calcedo R; Yox AD; Steet RA; Ruane T; O'Donnell P; Gao G; Wilson JM; Casal M; Ponder KP; Haskins ME
    Mol Ther; 2016 Feb; 24(2):206-216. PubMed ID: 26447927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histopathologic changes of the ear in canine models of mucopolysaccharidosis types I and VII.
    Hordeaux J; Deniaud J; Bemelmans I; Bertrand L; Moreau S; Amiaud J; Wyers M; Cherel Y; Colle MA
    Vet Pathol; 2011 May; 48(3):616-26. PubMed ID: 20930106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of neonatal enzyme replacement therapy and simvastatin treatment on cervical spine disease in mucopolysaccharidosis I dogs.
    Chiaro JA; O'Donnell P; Shore EM; Malhotra NR; Ponder KP; Haskins ME; Smith LJ
    J Bone Miner Res; 2014 Dec; 29(12):2610-7. PubMed ID: 24898323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathogenesis of mitral valve disease in mucopolysaccharidosis VII dogs.
    Bigg PW; Baldo G; Sleeper MM; O'Donnell PA; Bai H; Rokkam VR; Liu Y; Wu S; Giugliani R; Casal ML; Haskins ME; Ponder KP
    Mol Genet Metab; 2013 Nov; 110(3):319-28. PubMed ID: 23856419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early onset of lysosomal storage disease in a murine model of mucopolysaccharidosis type VII: undegraded substrate accumulates in many tissues in the fetus and very young MPS VII mouse.
    Vogler C; Levy B; Galvin N; Lessard M; Soper B; Barker J
    Pediatr Dev Pathol; 2005; 8(4):453-62. PubMed ID: 16222480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism of shortened bones in mucopolysaccharidosis VII.
    Metcalf JA; Zhang Y; Hilton MJ; Long F; Ponder KP
    Mol Genet Metab; 2009 Jul; 97(3):202-11. PubMed ID: 19375967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abnormalities in neural progenitor cells in a dog model of lysosomal storage disease.
    Walton RM; Wolfe JH
    J Neuropathol Exp Neurol; 2007 Aug; 66(8):760-9. PubMed ID: 17882020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long circulating enzyme replacement therapy rescues bone pathology in mucopolysaccharidosis VII murine model.
    Rowan DJ; Tomatsu S; Grubb JH; Haupt B; Montaño AM; Oikawa H; Sosa AC; Chen A; Sly WS
    Mol Genet Metab; 2012 Sep; 107(1-2):161-72. PubMed ID: 22902520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Upregulation of elastase activity in aorta in mucopolysaccharidosis I and VII dogs may be due to increased cytokine expression.
    Metcalf JA; Linders B; Wu S; Bigg P; O'Donnell P; Sleeper MM; Whyte MP; Haskins M; Ponder KP
    Mol Genet Metab; 2010 Apr; 99(4):396-407. PubMed ID: 20044292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biochemical basis of the beta-glucuronidase gene defect causing canine mucopolysaccharidosis VII.
    Ray J; Scarpino V; Laing C; Haskins ME
    J Hered; 1999; 90(1):119-23. PubMed ID: 9987917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Murine mucopolysaccharidosis type VII: the impact of therapies on the clinical course and pathology in a murine model of lysosomal storage disease.
    Vogler C; Sands MS; Galvin N; Levy B; Thorpe C; Barker J; Sly WS
    J Inherit Metab Dis; 1998 Aug; 21(5):575-86. PubMed ID: 9728337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cloning of the canine beta-glucuronidase cDNA, mutation identification in canine MPS VII, and retroviral vector-mediated correction of MPS VII cells.
    Ray J; Bouvet A; DeSanto C; Fyfe JC; Xu D; Wolfe JH; Aguirre GD; Patterson DF; Haskins ME; Henthorn PS
    Genomics; 1998 Mar; 48(2):248-53. PubMed ID: 9521879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inner ear pathology in the mucopolysaccharidosis VII mouse.
    Ohlemiller KK; Hennig AK; Lett JM; Heidbreder AF; Sands MS
    Hear Res; 2002 Jul; 169(1-2):69-84. PubMed ID: 12121741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enzyme replacement in murine mucopolysaccharidosis type VII: neuronal and glial response to beta-glucuronidase requires early initiation of enzyme replacement therapy.
    Vogler C; Levy B; Galvin NJ; Thorpe C; Sands MS; Barker JE; Baty J; Birkenmeier EH; Sly WS
    Pediatr Res; 1999 Jun; 45(6):838-44. PubMed ID: 10367775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of bone dysplasia by micro-CT and glycosaminoglycan levels in mouse models for mucopolysaccharidosis type I, IIIA, IVA, and VII.
    Rowan DJ; Tomatsu S; Grubb JH; Montaño AM; Sly WS
    J Inherit Metab Dis; 2013 Mar; 36(2):235-46. PubMed ID: 22971960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enzyme replacement therapy improves reproductive performance in mucopolysaccharidosis type VII mice but does not prevent postnatal losses.
    Soper BW; Pung AW; Vogler CA; Grubb JH; Sly WS; Barker JE
    Pediatr Res; 1999 Feb; 45(2):180-6. PubMed ID: 10022587
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variant clinical course of mucopolysaccharidosis type VII in two groups of mice carrying the same mutation.
    Casal ML; Wolfe JH
    Lab Invest; 1998 Dec; 78(12):1575-81. PubMed ID: 9881957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disease characteristics, effectiveness, and safety of vestronidase alfa for the treatment of patients with mucopolysaccharidosis VII in a novel, longitudinal, multicenter disease monitoring program.
    Giugliani R; Gonzalez-Meneses A; Scarpa M; Burton B; Wang R; Martins E; Oussoren E; Hennermann JB; Chabrol B; Grant CL; Sun A; Durand C; Hetzer J; Malkus B; Marsden D; Merritt Ii JL
    Orphanet J Rare Dis; 2024 May; 19(1):189. PubMed ID: 38715031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reversal of established bone pathology in MPS VII mice following lentiviral-mediated gene therapy.
    Derrick-Roberts AL; Panir K; Pyragius CE; Zarrinkalam KH; Atkins GJ; Byers S
    Mol Genet Metab; 2016 Nov; 119(3):249-257. PubMed ID: 27692945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abnormal osteoclast morphology and bone remodeling in a murine model of a lysosomal storage disease.
    Monroy MA; Ross FP; Teitelbaum SL; Sands MS
    Bone; 2002 Feb; 30(2):352-9. PubMed ID: 11856642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.